Contrary to this hypothesis, Fgfr3+ endosteal stromal cells deficient in p53 can give rise to osteosarcoma-like lesions through unregulated self-renewal and aberrant osteogenic processes [141]. The gene discussed is TP53; the disease is osteosarcoma.